Remus Pharmaceuticals Company Description
Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical finished formulations and products in India and internationally.
It is involved in trading of active pharmaceutical ingredient, as well as provides technical consultancy services to various distributors and contract manufacturing services.
The company offers capsule, cream, eye drop, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablets.
It has operations in Bhutan, Bolivia, Chile, Costa Rica, Cuba, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam.
The company was formerly known as Remus Pharmaceuticals Private Limited and changed its name to Remus Pharmaceuticals Limited in January 2023.
Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.
Country | India |
Founded | 2015 |
Industry | Drugs, Drug Proprietaries, and Druggists' Sundries |
Employees | 48 |
CEO | Arpit Shah |
Contact Details
Address: 1101 to 1103, South Tower Ahmedabad, Gujarat 380054 India | |
Phone | 91 79 2999 9857 |
Website | remuspharma.com |
Stock Details
Ticker Symbol | REMUS |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 5122 |
Key Executives
Name | Position |
---|---|
Arpit Shah | Chief Executive Officer |
Anjali Shah | Chief Financial Officer |